Forbion co-leads €129 million Series A financing of VectorY, one …

Nov 13, 2023  · Amsterdam, The Netherlands, November 13, 2023 – Forbion, a leading European life sciences venture capital firm, today announces that its Growth Opportunities Fund has co …


Install CouponFollow Chrome Extension   CouponFollow Extension

€129
OFF

Forbion Co-leads €129 Million Series A Financing Of VectorY, One …

2 days from now

Nov 13, 2023  · Amsterdam, The Netherlands, November 13, 2023 – Forbion, a leading European life sciences venture capital firm, today announces that its Growth Opportunities Fund has co …

forbion.com

€129
OFF

Forbion Co-leads €129 Million Series A Financing Of VectorY, One …

2 days from now

AMSTERDAM, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Forbion, a leading European life sciences venture capital firm, today announces that its Growth Opportunities Fund has co-led, together …

yahoo.com

€129
OFF

Forbion Co-leads €129 Million Series A Financing Of - GlobeNewswire

2 days from now

AMSTERDAM, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Forbion, a leading European life sciences venture capital firm, today announces that its Growth Opportunities Fund has co-led, together …

globenewswire.com

$138
OFF

VectorY Raises €129 Million ($138 Million) Series A Financing To ...

2 days from now

Nov 13, 2023  · Amsterdam, The Netherlands, November 13, 2023 – VectorY Therapeutics, a biotech company developing innovative vectorized antibody therapies for the treatment of …

vectorytx.com

$138
OFF

VectorY Raises €129 Million ($138 Million) Series A Financing To ...

2 days from now

Nov 13, 2023  · The investment will enable us to advance our lead program VTx-002, a potentially disease-modifying therapy for ALS, into clinical development. Our program is uniquely …

yahoo.com

$138
OFF

VectorY Raises €129 Million ($138 Million) Series A Financing To ...

2 days from now

Nov 13, 2023  · Round co-led by EQT Life Sciences and Forbion; Series A financing will support clinical development of the lead program in Amyotrophic Lateral Sclerosis (ALS), and …

businesswire.com

$138
OFF

Forbion-backed Biotech Raises $138M To Develop ALS Drug

2 days from now

Nov 14, 2023  · Three-year-old startup VectorY plans to use the Series A funding to advance a vectorized antibody for ALS into clinical testing. Netherlands-based biotechnology company …

biopharmadive.com

€129
OFF

Forbion Co-leads €129 Million Series A Financing Of VectorY, One …

2 days from now

AMSTERDAM, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Forbion, a leading European life sciences venture capital firm, today announces that its Growth Opportunities Fund has co-led, together …

yahoo.com

$138
OFF

EQT Life Sciences Co-Leads VectorY’s €129 Million ($138 Million)

2 days from now

Amsterdam, the Netherlands, November 14, 2023 – EQT Life Sciences is pleased to announce its investment in the €129 million ($138 million) Series A financing round of VectorY …

lspvc.com

$138
OFF

VectorY Raises €129 Million ($138 Million) Series A Financing To ...

2 days from now

Nov 13, 2023  · Round co-led by EQT Life Sciences and Forbion Series A financing will support clinical development of the lead program in Amyotrophic Lateral Sclerosis (ALS), and …

dutchnews.nl

€129
OFF

Forbion Co-leads 129 Million Series A Financing Of VectorY, …

2 days from now

STRITLY EMARGOED UNTIL 15:30PM ET, MONDAY 13 NOVEM ER 2023 Forbion co-leads €129 million Series A financing of VectorY, one of the largest private biotech financings in …

forbion.com

€129
OFF

Forbion Co-leads €129 Million Series A Financing Of VectorY, One …

2 days from now

Round co-led by Forbion and EQT Life SciencesFinancing will support clinical development of VTx-002, a potentially disease-modifying therapy for Amyotrophic Lateral Sclerosis (ALS) and …

quantisnow.com

€129
OFF

Forbion Co-leads €129 Million Series A Financing Of VectorY, One …

2 days from now

Nov 13, 2023  · Round co-led by Forbion and EQT Life Sciences Financing will support clinical development of VTx-002, a potentially disease-modifying therapy for Amyotrophic. About …

einpresswire.com

$138
OFF

VectorY Raises $138 Million In Series A Financing

2 days from now

Nov 13, 2023  · Dutch biotech company VectorY Therapeutics today announced the close of a 129 million-euro ($138 million) Series A financing. The proceeds will be used to advance its …

thepharmaletter.com

$138
OFF

VectorY Raises 129 Million ($138 Million) Series A Financing To …

2 days from now

VectorY Therapeutics | Amsterdam, The Netherlands | +31 20 226 80 20 | www.vectorytx.com | [email protected] VectorY Raises €129 Million ($138 Million) Series A Financing to Advance …

forbion.com

$138
OFF

VectorY Raises €129 Million ($138 Million) Series A Financing To ...

2 days from now

Nov 13, 2023  · AMSTERDAM--(BUSINESS WIRE)-- VectorY Therapeutics, a biotech company developing innovative vectorized antibody therapies for the treatment of neurodegenerative …

biospace.com

€129
OFF

Forbion Co-leads €129 Million Series A Financing Of VectorY, One …

2 days from now

Nov 13, 2023  · Round co-led by Forbion and EQT Life Sciences Financing will support clinical development of VTx-002, a potentially disease-modifying therapy for Amyotrophic Lateral …

businessupturn.com

FAQs about Forbion co-leads €129 million Series A financing of VectorY, one … Coupon?

Who has co-led 'vectory' seed financing?

Amsterdam, The Netherlands – 15 June 2021 – Forbion, a leading European life sciences venture capital firm, today announces that it has co-led the oversubscribed EUR 31 million seed financing of its portfolio company VectorY, together with a leading global investment firm. BioGeneration Ventures, and Eli Lilly & Company also joined the syndicate. ...

Does forbion's Growth Opportunities Fund II lead a series a financing?

Forbion’s Growth Opportunities Fund II co-led the Series A financing as announced today. ...

Is vectory a 'Growth Opportunities Fund' for forbion?

VectorY is a company built by Forbion through their Ventures arm, enabling initial proof of concept. Forbion is now supporting the company through their Growth Opportunities fund to further support the company through significant value-generating milestones. ...

Why did VectorY receive Series A financing?

VectorY raised €129 million ($138 million) in Series A financing. The funding was supported by a strong syndicate of European and US investors as an endorsement of the company's pioneering approach, world-class team, and commitment to developing therapies for patients with neurodegenerative diseases. ...

How much money has VectorY Therapeutics raised?

VectorY Therapeutics has raised €129 Million ($138 Million) in Series A Financing. ...

Who is forbion?

Forbion is a dedicated life sciences venture capital firm with offices in The Netherlands, Germany and Boston. Forbion invests in life sciences companies that are active in the (bio-)pharmaceutical space. Forbion manages €3 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension